FOR IMMEDIATE RELEASE
Date: April 28, 2026
Spearheading an instant liquidity solution for tokenized assets, Symbiotic and Midas announced an approach to address what many see as real‑world asset (RWA) markets' most significant pain point: poorly executing redemptions.
Using Symbiotic Core and Midas' Open Liquidity Architecture, the solution delivers a capital‑efficient approach that facilitates T+0 atomic settlement, eliminating the need for pre‑funded liquidity or levels of capital.
Solving the Liquidity Gap in Tokenized Markets
Tokenization has expanded access to traditional assets, but the lack of liquidity has been a problem. In some instances, the redemption mechanisms for tokenized funds take 60‑180 days, locking investors' capital and reducing its utility.
The platform's innovations tackle this problem with an onchain request‑for‑quote (RFQ). Redemption requests are made and various market participants bid to meet those requests, with the highest bid executed instantly. This enables the pricing and redemption to occur simultaneously, expediting the process.
Capital Efficiency Without Idle Funds
A key innovation behind the system is its ability to keep capital productive while still supporting instant settlement. Instead of requiring liquidity providers to pre‑fund positions, capital can remain deployed across decentralized finance protocols and be automatically recalled when needed.
This can be achieved via the new Symbiotic Core V2 upgrades that promote programmable capital facilities that promote enforceability while enabling capital to remain in play during the inter‑transaction period.
This means that liquidity providers can receive a return on their capital, while also allowing them to participate in settlements, eliminating the need to choose between efficiency and liquidity.
First Integration With Tokenized Funds
The infrastructure is already up and running on the Midas platform with Fasanara managing the first asset, a tokenized fund, mGLOBAL, which uses instant liquidity.
Midas has been focused on the creation of institutional‑grade tokenized investment funds, with more than $1.7 billion of assets issued and $37 million in returns paid out.
The integration with Arkimedes enables investors to redeem tokenized investments almost immediately, making onchain financial products more functional and attractive to investors compared to traditional markets.
Expanding the Role of Onchain Finance
The move comes at a time when decentralized finance is shifting focus from mere tokenization to creating financial infrastructure. Liquidity is emerging as a critical element in scaling tokenized assets to the mainstream market.
Instant convertibility and optimal capital allocation enabled by Symbiotic and Midas will provide the basis for tokenized assets to become more similar to other financial instruments while enjoying the advantages of transparency and programmability.
The system is also designed to be open. Any issuer can integrate tokenized assets into the liquidity layer, and qualified market participants can provide liquidity, creating a more inclusive and scalable ecosystem.
A Step Toward Mature Tokenized Markets
As tokenized finance continues to grow, solutions that address liquidity constraints are becoming critical. Without efficient exit mechanisms, even well‑structured assets struggle to gain adoption.
The introduction of instant liquidity infrastructure represents a meaningful step toward solving this problem. By combining real‑time settlement with capital efficiency, the model helps bridge the gap between blockchain‑based assets and traditional financial expectations.
About Symbiotic
Symbiotic is a blockchain infrastructure platform focused on powering collateral markets. It enables capital to remain productive while being committed to financial obligations, supporting applications across credit, insurance, and tokenized assets.
About Midas
Midas is a platform for tokenized investment products that allows institutions to bring financial strategies onchain. Its ecosystem supports composable assets designed for transparency, instant redemption, and DeFi integration.
Media Contact
Company: Symbiotic & Midas Contact: Media Relations Email: [email protected] Website: www.symbiotic.fi
Disclaimer
This press release is for informational purposes only and does not constitute financial or investment advice. Digital assets involve risk, and users should conduct their own research before engaging with tokenized financial products.
